Journal article
Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trial.
Abstract
OBJECTIVE: Numerous studies have demonstrated the efficacy of serotonergic antidepres-sants, particularly the selective serotonin reuptake inhibitors (SSRIs), in the treatment of social phobia. We evaluated the efficacy, safety, and tolerability of nefazodone, a 5-HT(2) antagonist, in patients with generalized social phobia (GSP).
METHOD: One hundred five patients with GSP (confirmed using the Structured Clinical Interview for DSM-IV) from 4 …
Authors
Van Ameringen M; Mancini C; Oakman J; Walker J; Kjernisted K; Chokka P; Johnston D; Bennett M; Patterson B
Journal
The Journal of Clinical Psychiatry, Vol. 68, No. 2, pp. 288–295
Publisher
Physicians Postgraduate Press
Publication Date
February 15, 2007
DOI
10.4088/jcp.v68n0215
ISSN
0160-6689